Evidence map›Paper›PMID 30293781›Full record

ArticleMolecular cell2018

Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction.

Han Han, Ruxi Qi, Jeff Jiajing Zhou, Albert Paul Ta, Bing Yang, Hiroki J Nakaoka, Gayoung Seo, Kun-Liang Guan, Ray Luo, Wenqi Wang

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Subcellular Cartography of the Phosphoinositide Multiverse.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2026
    Review
  3. Article
  4. Article
  5. Effects of L-Carnitine on the Developmental Competence of Bovine Oocytes.Animals : an open access journal from MDPI · 2025
    Article
  6. Article
  7. Review
  8. Synthetic Lipid Biology.Chemical reviews · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14.bioRxiv : the preprint server for biology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Han HanDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA.
Ruxi QiDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697, USA.
Jeff Jiajing ZhouDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA.
Albert Paul TaDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA.
Bing YangDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA.
Hiroki J NakaokaDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA.
Gayoung SeoDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA.
Kun-Liang GuanDepartment of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.
Ray LuoDepartment of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697, USA.
Wenqi WangDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA 92697, USA. Electronic address: wenqiw6@uci.edu.
University of California, Irvine · USUniversity of California, San Diego · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
PROTEIN PHOSPHORYLATION AND GROWTH FACTOR FUNCTIONR01GM051586 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROWN, JOAN HELLER · 1994 to 2024
$7.9M
AMBER force field consortium: a coherent biomolecular simulation platformR01GM079383 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CIEPLAK, PIOTR, DUAN, YONG · 2007 to 2017
$4.7M
The mTOR and Hippo pathway in cell growth and cancerR35CA196878 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUAN, KUN-LIANG · 2015 to 2019
$4.0M
Regulation and function of the Hippo pathway in growth controlR01GM126048 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Wenqi Wang · 2018 to 2026
$3.0M
AMBER/PBSA: An Open-Source Computer Program for Accurate and Scalable Solvation Analysis ofBiomoleculesR01GM093040 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LUO, RAY · 2010 to 2018
$2.2M
NCI NIH HHS P30 CA062203NCI NIH HHS R35 CA196878NIGMS NIH HHS R01 GM051586NIGMS NIH HHS R01 GM079383NIGMS NIH HHS R01 GM093040NIGMS NIH HHS R01 GM126048
6 · The paper itself

Abstract

The Hippo pathway plays a crucial role in organ size control and tumor suppression, but its precise regulation is not fully understood. In this study, we discovered that phosphatidic acid (PA)-related lipid signaling is a key regulator of the Hippo pathway. Supplementing PA in various Hippo-activating conditions activates YAP. This PA-related lipid signaling is involved in Rho-mediated YAP activation. Mechanistically, PA directly interacts with Hippo components LATS and NF2 to disrupt LATS-MOB1 complex formation and NF2-mediated LATS membrane translocation and activation, respectively. Inhibition of phospholipase D (PLD)-dependent PA production suppresses YAP oncogenic activities. PLD1 is highly expressed in breast cancer and positively correlates with YAP activation, suggesting their pathological relevance in breast cancer development. Taken together, our study not only reveals a role of PLD-PA lipid signaling in regulating the Hippo pathway but also indicates that the PLD-PA-YAP axis is a potential therapeutic target for cancer treatment.

Indexed as

Amino Acid SequenceAnimalsBreast NeoplasmsCell LineCell Line, TumorFemaleHEK293 CellsHippo Signaling PathwayHumansLipid MetabolismLong-Acting Thyroid StimulatorMiceMice, NudeNeurofibromin 2Nuclear ProteinsPhosphatidic AcidsLong-Acting Thyroid StimulatorNeurofibromin 2Nuclear ProteinsPhosphatidic AcidsPhospholipase Dphospholipase D1PhosphoproteinsProtein Serine-Threonine KinasesHippoLATSMOB1NF2phosphatidic acidphospholipase DRhoYAP

Identifiers

PMID30293781
PMCPMC6195446
OpenAlexW2895513420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.